Ara Partners, a private equity firm focused on industrial decarbonization investments, has committed $65 million in additional capital to BioVeritas, a bio-based ingredients company, to support the commercialization of the company’s production process for clean-label food and feed ingredients, gut health supplements and industrial materials.

The company has started delivering samples for testing to customers and potential partners, including major players in the clean-label ingredients market, from its market development unit in Bryan, Texas. The new funds raised by BioVeritas look to support upgrades to the market development unit, allowing for the delivery of large-scale, food-grade samples to customers and partners by quarter one of 2022, and the development of the company’s first commercial-scale production facility.

“This additional funding commitment accelerates the scale-up and commercialization of BioVeritas’ breakthrough technology,” says Cory Steffek, partner at Ara and chairman of the board of BioVeritas. “It also supports BioVeritas’ commitment to being a trusted partner for companies seeking natural, clean label solutions for food preservation, human and animal health, and industrial materials.”